The Dopaminergic and Anti-Neuroinflammatory Properties of Functionalized Nanoliposomes Containing Levodopa and Ibuprofen and Conjugated with Anti-Alpha-Synuclein Aptamer
- PMID: 40489035
- DOI: 10.1007/s11481-025-10227-0
The Dopaminergic and Anti-Neuroinflammatory Properties of Functionalized Nanoliposomes Containing Levodopa and Ibuprofen and Conjugated with Anti-Alpha-Synuclein Aptamer
Abstract
The purpose of this study was to design, synthesize, characterize, and evaluate the functionalized nanoliposomes containing levodopa and ibuprofen and conjugated with Anti-alpha-synuclein aptamer (FNLLICAASA). In this study, different aptamer sequences were designed and the best aptamer was selected. Then, the FNLLICAASA was synthesized, characterized, and the amount of dopamine level changes in SH-SY5Y cells after exposure to FNLLICAASA was evaluated. Also, the interferon-gamma (INFG) expression was assessed. The binding of FNLLICAASA to SH-SY5Y cells was also investigated using a fluorescent microscope and flow cytometry. The results of molecular docking and molecular dynamics simulation showed that aptamer APT46 with GAGGAG sequence was the best-chosen aptamer. The FNLLICAASA have a size range of 120 to 310 nm with an average positive zeta potential of 30 mV. The dopamine level change was increased in treated SH-SY5Y nerve cells, indicating the dopaminergic property of FNLLICAASA. Also, the expression of INFG was decreased in treated SH-SY5Y nerve cells, indicating the anti-neuroinflammatory property of FNLLICAASA. The binding tests showed the targeted binding of synthesized nanoliposomes to alpha-synuclein molecules on the cell surface of SH-SY5Y cells.
Keywords: Alpha-synuclein; Aptamer; Ibuprofen; Levodopa; Nanoliposome.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: Approval for the study was obtained from the Ethics Committee of Islamic Azad Tehran Medical Sciences University-Pharmacy and Pharmaceutical Branches Faculty. Competing Interests: The authors declare no competing interests.
References
-
- Aliakbari F, Shabani A, Bardania H, Eslampanah Seyedi HA, Mohammad-Beigi H, Tayaranian Marvian A et al (2017) Neurotoxicity of pre-incubated alpha-synuclein with neutral nanoliposomes on PC12 and SHSY5Y cell lines. Scientia Iranica 24(6):3542–3553
-
- Aliakbari F, Mohammad-Beigi H, Abbasi S, Rezaei‐Ghaleh N, Lermyte F, Parsafar S et al (2021) Multiple protective roles of Nanoliposome‐Incorporated Baicalein against Alpha‐Synuclein aggregates. Adv Funct Mater 31(7):2007765
-
- Allegritti E, Battista S, Maggi MA, Marconi C, Galantini L, Giansanti L (2023) Novel liposomal formulations for protection and delivery of levodopa: Structure-properties correlation. Int J Pharm 643:123230 - PubMed
-
- Angelova A, Angelov B (2017) Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair. Neural Regeneration Res 12(6):886–889
MeSH terms
Substances
LinkOut - more resources
Full Text Sources